Treprostinil and Losartan potassium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Treprostinil (treprostinil) and Losartan potassium (losartan potassium). Common drug interactions include diarrhoea among females and chronic obstructive pulmonary disease among males.

The phase IV clinical study analyzes what interactions people have when they take Treprostinil and Losartan potassium. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Treprostinil?

Treprostinil has active ingredients of treprostinil. eHealthMe is studying from 7,695 Treprostinil users. Check the latest studies of Treprostinil.

What is Losartan potassium?

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 51,511 Losartan potassium users. Check the latest studies of Losartan potassium.

On Jul, 12, 2026

11 people who take Treprostinil and Losartan potassium together, and have interactions are studied.

Treprostinil and Losartan potassium drug interactions.

What are the common drug interactions of Treprostinil and Losartan Potassium, by gender? *:

female:

Diarrhoea
Erythema (redness of the skin)
Feeling hot
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Infusion site erythema (reddening of the skin at infusion site)
Infusion site haemorrhage (bleeding from infusion site)
Infusion site pain
Infusion site pruritus (severe itching at infusion site)
Infusion site swelling
Postoperative wound infection

male:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Loss of consciousness
Blood pressure diastolic decreased
Breath sounds
Cough
Decreased appetite
Idiopathic pulmonary fibrosis (chronic lung disease)

What are the common drug interactions of Treprostinil and Losartan Potassium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal hernia
Cellulitis (infection under the skin)
Diarrhoea
Erythema (redness of the skin)
Feeling hot
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Infusion site erythema (reddening of the skin at infusion site)
Infusion site haemorrhage (bleeding from infusion site)
Infusion site pain
Infusion site pruritus (severe itching at infusion site)

50-59:

n/a

60+:

Hypotension (abnormally low blood pressure)
Loss of consciousness
Breath sounds
Cough
Decreased appetite
Dyspnoea (difficult or laboured respiration)
Fall
Idiopathic pulmonary fibrosis (chronic lung disease)
Lower limb fracture
Memory impairment

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 8 people, 72.73%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 9.09%
Infusion Site Pain: 1 person, 9.09%
Hypotension (abnormally low blood pressure): 1 person, 9.09%
Diarrhea: 1 person, 9.09%
Cardiac Disorder: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Treprostinil and Losartan potassium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously